FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3084989042> ?p ?o ?g. }

• W3084989042 abstract "Isolated limb infusion (ILI) is a minimally invasive procedure for delivering high-dose chemotherapy to extremities affected by locally advanced or in-transit melanoma. This study compared the outcomes of melanoma patients treated with ILI in the United States of America (USA) and Australia (AUS).Patients with locally recurrent in-transit melanoma treated with ILI at USA or AUS centers between 1992 and 2018 were identified. Demographic and clinicopathologic characteristics were collected. Primary outcomes of treatment response, in-field progression-free survival (IPFS), distant progression-free survival (DPFS), and overall survival (OS) were evaluated by the Kaplan-Meier method. Multivariable analysis evaluated whether availability of new systemic therapies affected outcomes.More ILIs were performed in AUS (n = 411, 60 %) than in the USA (n = 276, 40 %). In AUS, more ILIs were performed for stage 3B disease than in the USA (62 % vs 46 %; p < 0.001). The reported complete response rates were similar (AUS 30 % vs USA 29 %). Among the stage 3B patients, AUS patients had better IPFS (p = 0.001), whereas DPFS and OS were similar between the two countries. Among the stage 3C patients, the USA patients had better OS (p < 0.001), whereas IPFS and DPFS were similar. Availability of new systemic therapies did not affect IPFS or DPFS in either country. However, the USA patients who received ILI after ipilimumab approval in 2011 had significantly improved OS (hazard ratio, 0.62; p = 0.013).AUS patients were treated at an earlier disease stage than the USA patients with better IPFS for stage 3B disease. The USA patients treated after the availability of new systemic therapies had a better OS." @default.
• W3084989042 created "2020-09-21" @default.
• W3084989042 creator A5003970032 @default.
• W3084989042 creator A5010897664 @default.
• W3084989042 creator A5013063195 @default.
• W3084989042 creator A5015827608 @default.
• W3084989042 creator A5016734798 @default.
• W3084989042 creator A5018743654 @default.
• W3084989042 creator A5020180712 @default.
• W3084989042 creator A5021981756 @default.
• W3084989042 creator A5023204946 @default.
• W3084989042 creator A5024750878 @default.
• W3084989042 creator A5035263718 @default.
• W3084989042 creator A5036772413 @default.
• W3084989042 creator A5037037218 @default.
• W3084989042 creator A5045126641 @default.
• W3084989042 creator A5048126025 @default.
• W3084989042 creator A5048991418 @default.
• W3084989042 creator A5050528758 @default.
• W3084989042 creator A5050823888 @default.
• W3084989042 creator A5056708868 @default.
• W3084989042 creator A5057498874 @default.
• W3084989042 creator A5063467902 @default.
• W3084989042 creator A5072924814 @default.
• W3084989042 creator A5081500675 @default.
• W3084989042 creator A5085976507 @default.
• W3084989042 creator A5090093312 @default.
• W3084989042 date "2020-09-11" @default.
• W3084989042 modified "2023-10-16" @default.
• W3084989042 title "Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia" @default.
• W3084989042 cites W1810160594 @default.
• W3084989042 cites W1965370740 @default.
• W3084989042 cites W1982150872 @default.
• W3084989042 cites W1988319163 @default.
• W3084989042 cites W1990935194 @default.
• W3084989042 cites W1996062649 @default.
• W3084989042 cites W1998402899 @default.
• W3084989042 cites W2007984865 @default.
• W3084989042 cites W2019607817 @default.
• W3084989042 cites W2021347851 @default.
• W3084989042 cites W2028093628 @default.
• W3084989042 cites W2028699294 @default.
• W3084989042 cites W2035464744 @default.
• W3084989042 cites W2049903029 @default.
• W3084989042 cites W2067553137 @default.
• W3084989042 cites W2076055196 @default.
• W3084989042 cites W2078503113 @default.
• W3084989042 cites W2087676114 @default.
• W3084989042 cites W2095242372 @default.
• W3084989042 cites W2097995306 @default.
• W3084989042 cites W2103707167 @default.
• W3084989042 cites W2109274792 @default.
• W3084989042 cites W2118863192 @default.
• W3084989042 cites W2126463731 @default.
• W3084989042 cites W2128035403 @default.
• W3084989042 cites W2128758225 @default.
• W3084989042 cites W2152897456 @default.
• W3084989042 cites W2156167210 @default.
• W3084989042 cites W2242240508 @default.
• W3084989042 cites W2682116888 @default.
• W3084989042 cites W2761169565 @default.
• W3084989042 cites W2897056135 @default.
• W3084989042 cites W2924571947 @default.
• W3084989042 cites W2939676267 @default.
• W3084989042 cites W3010867317 @default.
• W3084989042 cites W3011108679 @default.
• W3084989042 cites W4229709118 @default.
• W3084989042 doi "https://doi.org/10.1245/s10434-020-09051-y" @default.
• W3084989042 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7674259" @default.
• W3084989042 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32918177" @default.
• W3084989042 hasPublicationYear "2020" @default.
• W3084989042 type Work @default.
• W3084989042 sameAs 3084989042 @default.
• W3084989042 citedByCount "6" @default.
• W3084989042 countsByYear W30849890422020 @default.
• W3084989042 countsByYear W30849890422021 @default.
• W3084989042 countsByYear W30849890422022 @default.
• W3084989042 countsByYear W30849890422023 @default.
• W3084989042 crossrefType "journal-article" @default.
• W3084989042 hasAuthorship W3084989042A5003970032 @default.
• W3084989042 hasAuthorship W3084989042A5010897664 @default.
• W3084989042 hasAuthorship W3084989042A5013063195 @default.
• W3084989042 hasAuthorship W3084989042A5015827608 @default.
• W3084989042 hasAuthorship W3084989042A5016734798 @default.
• W3084989042 hasAuthorship W3084989042A5018743654 @default.
• W3084989042 hasAuthorship W3084989042A5020180712 @default.
• W3084989042 hasAuthorship W3084989042A5021981756 @default.
• W3084989042 hasAuthorship W3084989042A5023204946 @default.
• W3084989042 hasAuthorship W3084989042A5024750878 @default.
• W3084989042 hasAuthorship W3084989042A5035263718 @default.
• W3084989042 hasAuthorship W3084989042A5036772413 @default.
• W3084989042 hasAuthorship W3084989042A5037037218 @default.
• W3084989042 hasAuthorship W3084989042A5045126641 @default.
• W3084989042 hasAuthorship W3084989042A5048126025 @default.
• W3084989042 hasAuthorship W3084989042A5048991418 @default.
• W3084989042 hasAuthorship W3084989042A5050528758 @default.
• W3084989042 hasAuthorship W3084989042A5050823888 @default.
• W3084989042 hasAuthorship W3084989042A5056708868 @default.
• W3084989042 hasAuthorship W3084989042A5057498874 @default.
• W3084989042 hasAuthorship W3084989042A5063467902 @default.

• next